| September 16, 2026
MENLO PARK, Calif. –(BUSINESS WIRE)–Sep. 16, 2026– AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical-stage biopharmaceutical company developing novel small molecule therapeutics derived from its boron chemistry platform, today announced it granted inducement equity awards to Cameron Trenor,